Cartesian Therapeutics Inc (NAS:RNAC)
$ 27.08 2.33 (9.41%) Market Cap: 481.92 Mil Enterprise Value: 347.49 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 45/100

Cartesian Therapeutics Inc (RNAC) Transcripts

  • 1